EFEMadrid Desk

The European Medicines Agency on Thursday approved the use of the Pfizer/BioNTech Covid-19 vaccine in children aged 5-11.

The vaccination, which contains a lower dose than the one used on 12 year olds, will consist of two jabs administered three weeks apart.

“The benefits of Comirnaty in children aged 5 to 11 outweigh the risks, particularly in those with conditions that increase the risk of severe Covid-19,” the health authority said in a statement.